LYNBROOK, N.Y. (AP) _ BioSpecifics Technologies Corp. (BSTC) on Monday reported fourth-quarter profit of $7.4 million.
On a per-share basis, the Lynbrook, New York-based company said it had profit of $1.
The biopharmaceutical company posted revenue of $11.8 million in the period.
For the year, the company reported profit of $24.5 million, or $3.33 per share. Revenue was reported as $38.2 million.
BioSpecifics shares have dropped 9% since the beginning of the year. In the final minutes of trading on Monday, shares hit $51.80, a fall of 23% in the last 12 months.